We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+19.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$160M
AUM Growth
+$21.9M
Cap. Flow
+$13.5M
Cap. Flow %
8.44%
Top 10 Hldgs %
39.05%
Holding
148
New
10
Increased
63
Reduced
28
Closed
10

Top Buys

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$6.32M
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.84M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$1.67M
4
IPGP icon
IPG Photonics
IPGP
+$733K
5
IBB icon
iShares Biotechnology ETF
IBB
+$676K

Top Sells

Rank Stock Value
1
EWC icon
iShares MSCI Canada ETF
EWC
+$726K
2
CAB
Cabela's Inc
CAB
+$591K
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$546K
4
BKLN icon
Invesco Senior Loan ETF
BKLN
+$509K
5
IDU icon
iShares US Utilities ETF
IDU
+$412K

Sector Composition

Rank Sector Weight
1 Healthcare 33.04%
2 Energy 9.32%
3 Consumer Staples 6.79%
4 Technology 6.15%
5 Consumer Discretionary 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13M 8.13%
418,010
+136,553
+49% +$3.84M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12.4M 7.77%
229,577
-9,300
-4% -$546K
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10.6M 6.61%
246,382
+197,989
+409% +$6.32M
MO icon
4
Altria Group
MO
$125B
$4.39M 2.75%
69,244
+3,456
+5% +$230K
GILD icon
5
Gilead Sciences
GILD
$165B
$4.22M 2.64%
52,033
+899
+2% +$68.7K
META icon
6
Meta Platforms (Facebook)
META
$1.49T
$4.18M 2.62%
24,483
+505
+2% +$84.3K
CVS icon
7
CVS Health
CVS
$135B
$3.94M 2.47%
48,473
-300
-0.6% -$23.7K
IYK icon
8
iShares US Consumer Staples ETF
IYK
$1.44B
$3.61M 2.26%
89,676
+906
+1% +$36.7K
BIIB icon
9
Biogen
BIIB
$30.9B
$3.1M 1.94%
9,900
+100
+1% +$29.6K
PM icon
10
Philip Morris
PM
$309B
$3M 1.88%
27,042
+519
+2% +$60.4K
IRM icon
11
Iron Mountain
IRM
$35.9B
$2.91M 1.82%
74,762
-668
-0.9% -$25K
JNJ icon
12
Johnson & Johnson
JNJ
$640B
$2.58M 1.61%
19,823
-65
-0.3% -$8.62K
V icon
13
Visa
V
$677B
$2.42M 1.51%
22,967
+1,007
+5% +$102K
UNP icon
14
Union Pacific
UNP
$174B
$2.16M 1.35%
18,660
+120
+0.6% +$12.9K
WY icon
15
Weyerhaeuser
WY
$17.6B
$2.01M 1.26%
59,020
+760
+1% +$25K
XOM icon
16
ExxonMobil
XOM
$650B
$1.99M 1.24%
24,235
-200
-0.8% -$15.9K
AAPL icon
17
Apple
AAPL
$4.97T
$1.97M 1.23%
51,092
+3,148
+7% +$122K
MGK icon
18
Vanguard Morningstar Mega Cap Growth ETF
MGK
$31.3B
$1.95M 1.22%
92,955
+11,215
+14% +$231K
EMLP icon
19
First Trust North American Energy Infrastructure Fund
EMLP
$4.1B
$1.9M 1.19%
76,515
+4,197
+6% +$104K
PSX icon
20
Phillips 66
PSX
$82.9B
$1.87M 1.17%
20,458
+450
+2% +$38.1K
AGIO icon
21
Agios Pharmaceuticals
AGIO
$2.08B
$1.86M 1.16%
+27,850
New +$1.67M
YUMC icon
22
Yum China
YUMC
$15.7B
$1.85M 1.16%
46,304
+1,700
+4% +$63.4K
GLNG icon
23
Golar LNG
GLNG
$4.82B
$1.83M 1.14%
80,850
+2,700
+3% +$59.3K
SBAC icon
24
SBA Communications
SBAC
$19.8B
$1.8M 1.13%
12,500
-700
-5% -$99.7K
IMGN
25
DELISTED
Immunogen Inc
IMGN
$1.69M 1.06%
220,500
+2,000
+0.9% +$13.3K
1
2 3 4 5

Similar funds

CIM
Chiron Investment Management New York $300M AUM 49.09% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
FWM
Fairhaven Wealth Management Oak Brook, Illinois $320M AUM 17.7% 1-Year Est. Return
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
AP
Agilis Partners Waltham, Massachusetts $332M AUM 10.57% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Fernwood Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Fernwood Investment Management held 148 positions worth $160M, up 16% from $138M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fernwood Investment Management deployed $13.5M of net new capital in Q3 2017, opening 10 new positions and adding to 63 existing holdings. Its largest new stake was Agios Pharmaceuticals: 27,850 shares worth $1.86M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Portola Pharmaceuticals, Inc., an estimated $546K trimmed.

  • Fernwood Investment Management's largest Q3 2017 buy was Agios Pharmaceuticals: 27,850 shares worth $1.86M.
  • Fernwood Investment Management added most to MyoKardia, Inc. Common Stock in Q3 2017, an estimated $6.32M increase.
  • Fernwood Investment Management's biggest Q3 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $546K.
  • Fernwood Investment Management fully exited iShares MSCI Canada ETF in Q3 2017, selling an estimated $726K.
  • Fernwood Investment Management's ten largest holdings make up 39% of its $160M portfolio in Q3 2017.
  • Fernwood Investment Management opened 10 new positions and closed 10 in Q3 2017.
  • Fernwood Investment Management's portfolio value rose 16% quarter-over-quarter to $160M.

Based on Fernwood Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.